Human CD160 Protein, His Tag
分子別名(Synonym)
CD160,BY55,NK1,NK28
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human CD160, His Tag (BY5-H5229) is expressed from human 293 cells (HEK293). It contains AA Ile 27 - Ser 159 (Accession # O95971-1).
Predicted N-terminus: Ile 27
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 16.7 kDa. The protein migrates as 25-28 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>90% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
CD160抗原也被稱為自然殺傷細(xì)胞受體BY55,是一種27kDa的糖蛋白,含有1個(gè)Ig樣V型(免疫球蛋白樣)結(jié)構(gòu)域。其表達(dá)與外周血NK細(xì)胞和具有細(xì)胞溶解效應(yīng)活性的CD8 T淋巴細(xì)胞密切相關(guān)。CD160在細(xì)胞表面表達(dá)為緊密二硫鍵連接的多聚體。在組織中,CD160在所有腸上皮內(nèi)淋巴細(xì)胞上表達(dá)。CD160顯示出與經(jīng)典和非經(jīng)典MHC I類分子結(jié)合的廣泛特異性。當(dāng)在血管內(nèi)皮細(xì)胞上表達(dá)時(shí),CD160傳播抗血管生成信號(hào)并促進(jìn)細(xì)胞凋亡。
關(guān)鍵字: CD160;CD160蛋白;CD160重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。